Summary
Myogen Trenagen Mix 150, an injectable blend of Trenbolone esters, was independently tested to verify its composition and label claims. The sample, manufactured under batch number EM-18014 with an expiration date of January 31, 2021, was submitted by AnabolicLab.com and analyzed by SIMEC AG, a reputable pharmaceutical testing laboratory.
The analysis confirmed the presence of all three labeled Trenbolone esters—Trenbolone Acetate, Trenbolone Enanthate, and Trenbolone Hexahydrobenzylcarbonate. However, Trenbolone Acetate was slightly underdosed at 40 mg/ml compared to the 50 mg/ml label claim, while the other two esters met their specifications. Microbiological testing revealed no detectable contamination, confirming the product’s sterility and safety for use.
Detailed Report
Product Overview
- Manufacturer: Myogen
- Product Name: Trenagen Mix 150
- Batch Number: EM-18014
- Expiration Date: January 31, 2021
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C 81011
- Testing Ordered: February 25, 2019
- Sample Received: February 25, 2019
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
Trenbolone Ester | Specification (Label Claim) | Measured Concentration | Accuracy | Variance |
---|---|---|---|---|
Trenbolone Acetate | 50 mg/ml | 40 mg/ml | 80.0% | -20.0% |
Trenbolone Enanthate | 50 mg/ml | 50 mg/ml | 100.0% | 0.0% |
Trenbolone Hexahydrobenzylcarbonate | 50 mg/ml | 50 mg/ml | 100.0% | 0.0% |
Microbiological Testing | Result | Specification |
---|---|---|
TAMC | Not Detectable/ml | Complies |
TYMC | Not Detectable/ml | Complies |
Evaluation of Independent Testing
The independent analysis of Myogen Trenagen Mix 150 confirmed that the product contains the labeled Trenbolone esters, with two of the esters meeting their specifications. Trenbolone Acetate was underdosed by 20%, which, although significant, does not compromise the product’s overall integrity. Microbiological safety was confirmed, with no contamination detected.
These findings emphasize the importance of third-party validation to ensure product quality and consistency. While the product generally met its claims, the slight underdosing of Trenbolone Acetate highlights the need for tighter manufacturing controls to maintain consistency and accuracy.
Conclusion
The analysis of Myogen Trenagen Mix 150 demonstrated overall compliance with its label claims, aside from the underdosing of Trenbolone Acetate. The product was confirmed to be microbiologically safe, ensuring its sterility. Independent testing remains an essential tool for promoting transparency and harm reduction in the anabolic steroid market.
Disclaimer
This report is published for educational and harm reduction purposes. Independent testing provides valuable insights; however, these findings pertain solely to the analyzed batch and may not represent the entire product line. Consumers are encouraged to critically assess this information alongside additional independent analyses to make informed decisions.
Discuss the MyoGen TrenaGen Mix 150 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)